IDXX

Q: What is the price of IDEXX Laboratories (IDXX) today?

The current price of IDEXX Laboratories (IDXX) is $ 585.69, representing a 47.49% gain over the past year. The stock began the year trading around $ 676.53 and is currently priced at $ 585.69. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does IDEXX Laboratories (IDXX) pay dividends?

IDEXX Laboratories (IDXX) did not pay dividends over the past year.

IDEXX Laboratories Inc.

Price

$ 585.69

return (12m)

47.49%

p/e

43.01

p/bv

28.38

DIVIDEND YIELD

0.00%

IDXX price

IDXX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment IDXX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-2.20%

3 months

-17.90%

1 year

47.49%

2 years

12.67%

5 years

15.65%

10 years

629.01%

Fundamentals IDXX

review the fundamentals of IDEXX Laboratories shares

P/E

43.01

Sector: -2.15 Industry: 0.38

P/S (PSR)

10.59

Sector: 1.92 Industry: 2.43

P/BV

28.38

Sector: 2.10 Industry: 2.24

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

31.62%

Sector: -25.33% Industry: -23.48%

ROE

65.99%

Sector: -29.65% Industry: -31.19%

ROIC

38.39%

Sector: -418.66% Industry: -76.94%

NET MARGIN

24.62%

Sector: -27.82% Industry: -30.15%

GROSS MARGIN

61.80%

Sector: 44.91% Industry: 51.03%

OPERATING MARGIN

31.60%

Sector: -22.85% Industry: -26.89%

EV/EBITDA

31.02

Sector: -0.40 Industry: 1.11

EV/EBIT

33.44

Sector: -1.68 Industry: -0.22

PRICE-TO-ASSETS

13.60

Sector: 1.13 Industry: 1.20

BVPS

20.07

Sector: 3.83 Industry: 5.09

EPS

13.24

Sector: -0.89 Industry: -0.80

EQUITY-TO-ASSETS RATIO

0.48

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

0.52

Sector: 0.46 Industry: 0.50

CAGR REVENUE 5 YEARS

6.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

7.30%

Sector: - Industry: -

FAIR VALUE OF IDEXX Laboratories ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 585.69

Fair Value

$ 0.00

Upside/Downside Return potential.

-86.80%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals IDXX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.57	35.11	86.53%	0.67%	$ 837.34 B	31.66%
ISRG	56.19	8.94	15.92%	0.00%	$ 160.48 B	28.38%
TMO	27.56	3.45	12.52%	0.35%	$ 184.79 B	15.05%
SNY	12.82	1.39	10.86%	4.62%	$ 116.90 B	18.68%
NVS	21.09	6.34	30.04%	4.53%	$ 294.97 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.09	2.26	9.38%	3.27%	$ 111.15 B	13.00%
CVS	52.79	1.24	2.35%	3.62%	$ 93.33 B	0.44%
GSK	14.82	5.29	35.71%	2.96%	$ 113.04 B	17.48%
BSX	32.15	0.00	0.00%	0.00%	$ 93.16 B	14.44%
TMDX	17.99	7.24	40.22%	0.00%	$ 3.42 B	31.43%
HCA	15.86	-38.82	-244.82%	0.62%	$ 107.58 B	8.97%
RMD	22.02	5.18	23.51%	1.04%	$ 32.72 B	27.53%
DHR	37.39	2.57	6.88%	0.67%	$ 135.12 B	14.71%
INMD	9.26	1.27	13.73%	0.00%	$ 868.77 M	25.32%
PHG	24.85	2.00	8.06%	3.27%	$ 25.78 B	5.07%
FMS	11.36	0.77	6.75%	3.51%	$ 12.82 B	5.02%
SYK	39.12	5.66	14.48%	1.03%	$ 126.98 B	12.92%
CI	10.45	0.00	0.00%	2.26%	$ 71.83 B	2.50%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

IDXX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT IDEXX Laboratories

IDEXX Laboratories Inc.

Average Investor10 user rating

5.0 (29 people)

United States

43 years

Founded: 1983

1991

Time since IPO - 35 years

10.350

Employees

IDEXX Laboratories Inc. (United States) is listed on the Nasdaq and has a market capitalization of $45.56 Billions, with shareholders equity totaling $1.61 Billion.

The company employs approximately 10.350 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, IDEXX Laboratories Inc. reported $4.30 Billions in revenue, generating net income of $1.06 Billion.

Key financial metrics include a P/E ratio of 43.01, a price-to-book (P/B) ratio of 28.38, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker IDXX.

Market cap

$ 45.56 Billions

Net worth

$ 1.61 Billion

$ 1,605,380,000.00

Assets

$ 3.35 Billions

$ 3,350,760,000.00

Total Shares Outstanding

80.00 Millions

80,000,000

Average Daily Trading Volume

$ 529.77 Thousand

$ 529,774.14

Sector

Health

Industry

Medical Supplies and Equipment

IDXX

revenue by Business Segment IDEXX Laboratories

Revenue by Region IDEXX Laboratories

IDXX revenue and profits

Financial Results IDXX

DRAG THE FRAME TO SEE MORE DATA

IDXX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 79.16 20,24% (12M)

P/E

52.79

3.62%

ROE

2.35%

P/BV

1.24

CI - Cigna

$ 278.37 --13,14% (12M)

P/E

10.45

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 37.27 --40,26% (12M)

P/E

-2.59

0.00%

ROE

-33.28%

P/BV

0.86

HUM - Humana

$ 197.45 --30,67% (12M)

P/E

17.96

1.99%

ROE

6.70%

P/BV

1.20

HCA - HCA Healthcare

$ 510.27 53,37% (12M)

P/E

15.86

0.62%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 959.08 31,90% (12M)

P/E

40.57

0.67%

ROE

86.53%

P/BV

35.11

NVS - Novartis

$ 155.47 58,82% (12M)

P/E

21.09

4.53%

ROE

30.04%

P/BV

6.34

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 79.16 20,24% (12 M)

P/L

52.79

3.62%

ROE

2.35%

P/VP

1.24

CI - Cigna

$ 278.37 --13,14% (12 M)

P/L

10.45

2.26%

ROE

0.00%

P/VP

0.00

CNC - Centene

$ 37.27 --40,26% (12 M)

P/L

-2.59

0.00%

ROE

-33.28%

P/VP

0.86

HUM - Humana

$ 197.45 --30,67% (12 M)

P/L

17.96

1.99%

ROE

6.70%

P/VP

1.20

HCA - HCA Healthcare

$ 510.27 53,37% (12 M)

P/L

15.86

0.62%

ROE

-244.82%

P/VP

-38.82

LLY - Eli Lilly

$ 959.08 31,90% (12 M)

P/L

40.57

0.67%

ROE

86.53%

P/VP

35.11

NVS - Novartis

$ 155.47 58,82% (12 M)

P/L

21.09

4.53%

ROE

30.04%

P/VP

6.34

Frequently Asked Questions

What is the price of IDEXX Laboratories (IDXX) today?

The current price of IDEXX Laboratories (IDXX) is $ 585.69, representing a 47.49% gain over the past year. The stock began the year trading around $ 676.53 and is currently priced at $ 585.69. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does IDEXX Laboratories (IDXX) pay dividends?

IDEXX Laboratories (IDXX) did not pay dividends over the past year.

Is IDEXX Laboratories (IDXX) a good investment?

IDEXX Laboratories (IDXX) is currently trading at $ 585.69 with a P/E ratio of 43.01%. This represents a 4,662% premium compared to its historical average P/E. Over the past year, the stock has gained 47.49 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 47.49%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy IDEXX Laboratories (IDXX) stock?

You can buy IDEXX Laboratories (IDXX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol IDXX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of IDEXX Laboratories (IDXX) yield today?

Over the past month, IDEXX Laboratories (IDXX) has returned -2.20% — 47.49% over the past year, and 15.65% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of IDEXX Laboratories (IDXX) today at the current price of $ 585.69 your total investment would be $ 58,568.50.

Based on historical performance, the investment would have grown to approximately:

$ 86,382.68 after 1 year
$ 67,734.47 after 5 years
$ 426,970.22 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

IDXX

IDEXX Laboratories Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment IDXX

review the fundamentals of IDEXX Laboratories shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT IDEXX Laboratories

IDEXX Laboratories Inc.

United States

43 years

1991

10.350

PROFIT X PRICE IDXX

Financial Results IDXX

IDXX cash flow

Asset, Revenue and Profit Growth - IDXX

IDXX balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

LLY - Eli Lilly

NVS - Novartis

Frequently Asked Questions